Expression data for multiple cancer cell lines (not shown) suggested ARHGEF10 as a more likely target gene than CLN8, since ARHGEF10 expression was decreased by more than 50% in 83% (15/18) of lines tested. This evidence concerns the gene CLN8 and cancer.